JO2236B1 - Carbamic acid derivatives - Google Patents
Carbamic acid derivativesInfo
- Publication number
- JO2236B1 JO2236B1 JO200049A JOP20000049A JO2236B1 JO 2236 B1 JO2236 B1 JO 2236B1 JO 200049 A JO200049 A JO 200049A JO P20000049 A JOP20000049 A JO P20000049A JO 2236 B1 JO2236 B1 JO 2236B1
- Authority
- JO
- Jordan
- Prior art keywords
- lower alkyl
- signifies
- hydrogen
- phenyl
- caused
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to compounds of formula Wherein R1 signifies hydrogen or lower alkyl R2.R3 signify, independently from each other, hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl X signifies O,S or two hydrogen, atoms not forming a bridge A1/A2 signify, independently from each other, phenyl or a 6-membered heterocycle containing 1 or 2 nitrogen atoms B is a group of formula Wherein R3 signifies lower alkyl, lower alkenyl, lower alkinyl, benzyl, lower alkyl- cycloalkyl, lower alkyl- cyano, lower alkyl- pyridinyl, lower alkyl-lower, lower alkoxy-phenyl, lower alkyl-phenyl, which is optionally substituted by lower alkoxy, or phenyl, which is optionally substituted by lower alkoxy, or lower alkyl-thienyl, cycloalkyl, lower alkyl- trifluoromethyl, or lower alkyl – morpholinyl, Y signifies –O,S or a bond Z signifies O.or S Or B is a -5- membered heterocyclic group of formula Wherein R4 and R5 signifies hydrogen, lower alkyl, lower alkoxy, cyclohexyl, lower alkyl- cyclohexyl or trifluoromethyl, with the proviso that at least one of R4 or R5 has to be hydrogen as well as to their pharmaceutically acceptable salts These compounds may be used in the control or prevention of acute and or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia caused by pregnancy, cardiac arrest, hypoglycaemia, alheimer’s disease, huntington’s chorea, Als, dementia caused by AIDS , eye injuries, retinopathy, cognitive disorders, memory deficits, schizophrenia, idiopathic parkinsonism or parkinsonism caused by medicaments as well as conditions which lead to glutamate deficiency functions, such as e’g, muscle spasms, convulsions, migraine, urinary incontinence, nicotine addiction, psychoses, opiate addition, anxiety, vomiting , acute and chronic pain, dyskinesia and depression
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JO200049A JO2236B1 (en) | 2000-04-13 | 2000-04-13 | Carbamic acid derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JO200049A JO2236B1 (en) | 2000-04-13 | 2000-04-13 | Carbamic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
JO2236B1 true JO2236B1 (en) | 2004-10-07 |
Family
ID=48052137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JO200049A JO2236B1 (en) | 2000-04-13 | 2000-04-13 | Carbamic acid derivatives |
Country Status (1)
Country | Link |
---|---|
JO (1) | JO2236B1 (en) |
-
2000
- 2000-04-13 JO JO200049A patent/JO2236B1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY126586A (en) | Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands | |
CA2243234A1 (en) | 5h-thiazolo[3,2-a]pyrimidine derivatives | |
RU2356903C2 (en) | C-6 modified indazolyl pyrrolotriazines | |
RS20050195A (en) | Heterocyclic substituted piperazines for the treatment of schizophrenia | |
ATE122233T1 (en) | METHOD FOR USING (2-IMIDAZOLINE-2-YLAMINO)-QUINOXALINES FOR LOWERING OR STABILIZING INTRAOCULAR PRESSURE. | |
WO2001029011A3 (en) | Benzodiazepine derivatives as metabotropic glutamate receptor antagonists | |
TW200505907A (en) | Piperidine-benzenesulfonamide derivatives | |
PE20010759A1 (en) | BENZODIAZEPINE DERIVATIVES AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEPTOR | |
EA200300718A1 (en) | 3-INDOLINE DERIVATIVES THAT CAN BE APPLIED FOR THE TREATMENT OF PSYCHIATRIC AND NEUROLOGICAL DISORDERS | |
MXPA04000278A (en) | Use of nk-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury. | |
PE20021072A1 (en) | DERIVATIVES OF DIHYDRO-BENZO (b) (1,4) -DIAZEPIN-2-ONA AS ANTAGONISTS I OF mGLUR2 | |
ATE501141T1 (en) | CONDENSED BIZYCLIC SUBSTITUTED AMINE AS HISTAMINE 3 RECEPTOR LIGANDS | |
HRP20090143T3 (en) | N-oxides as prodrugs of piperazine&piperidine derivatives | |
PE135299A1 (en) | DERIVATIVES OF 1,3,8-TRIAZA-ESPIRO [4,5] DECAN-4-ONA | |
PE20010494A1 (en) | SUBSTITUTE PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | |
JO2307B1 (en) | Pyrimidine derivatives | |
JO2236B1 (en) | Carbamic acid derivatives | |
MXPA02011464A (en) | 1,4 diazepan 2,5 dione derivatives and their use as nk 1 receptor antagonists. | |
CA2388470A1 (en) | Use of carbonylamino derivatives against cns disorders | |
CA2437006A1 (en) | Aminotriazolopyridine derivatives as adenosine receptor ligands | |
MXPA04005554A (en) | Benzothiazoles. | |
EP0449195A3 (en) | Aminobenzene compounds, their production and use | |
DK0630893T3 (en) | N, N'-disubstituted amide derivative | |
PL1603877T3 (en) | NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS | |
ECSP003444A (en) | DERIVATIVES OF CARBAMIC ACID |